Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor on the listing of LEPU ScienTech Medical Technology while Wilson Sonsini Goodrich &...
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.’s Listing on the Main Board of the Hong Kong Stock Exchange
Jenscare Scientific’s Hong Kong IPO
O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...
Sanofi’s €300 Million Strategic Equity Investment in Innovent Biologics
Herbert Smith Freehills has advised Sanofi on the deal. The innnovative global healthcare company Sanofi announced its €300 million strategic equity investment in Chinese biopharmaceutical company...
Biocytogen Pharmaceuticals’ Listing on the Main Board of the Hong Kong Stock Exchange
Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the company’s official listing...
Linmon Media Limited’s HK$420 Million Initial Public Offering
Harneys acted as Cayman Islands counsel to Linmon Media Limited on the matter. Clifford Chance provided Hong Kong and US legal advice and CM Law Firm...
ClouDr’s US$15 Million Initial Public Offering and Listing
Herbert Smith Freehills and its joint operation partner Kewei advised Sanofi on the deal. Sanofi participated in the initial public offering and listing of ClouDr in...
Zhongyuan Bank Co., Ltd.’s HK$5,670 Million Placement
Herbert Smith Freehills has advised the placing agents and joint global coordinators. Huatai Financial Holdings (Hong Kong) Limited, CLSA Limited, China Securities (International) Corporate Finance Company...
Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
Bio-heart Biological Technology Co. Ltd.’s Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills has advised Huatai Financial Holdings (Hong Kong) Limited. O’Melveny & Myers represented Bio-heart on the deal. Huatai Financial Holdings (Hong Kong) Limited acted...
Peijia Medical Limited’s Listing On The Hong Kong
Herbert Smith Freehills has advised Morgan Stanley Asia Limited and Huatai Financial Holdings as joint sponsors. O’Melveny & Myers LLP and and Jingtian & Gongcheng advised...